ConductScience.org, home

Paper · 14499350

A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.

Chen L and 4 others. Bone, 2003. Cited by 137 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Papers, record 14499350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14499350

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
PubMed
Journal
Bone
PubMed
Year
2003
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
137
iCite
Relative citation ratio, by iCite
2.73
iCite
Revised in PubMed
2019-09-06
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen LLin
2Li DDan
3Li CCuiling
4Engel AApril
5Deng CXChu-Xia

Source PubMed

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcrocephalosyndactyliaMajor topic
Bone DevelopmentMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Amino Acid Substitution
Animals
Apoptosis
Cell Differentiation
Cell Division
Cranial Sutures
Heterozygote
Mice
Mice, Mutant Strains
Osteoblasts
Phenotype
Proto-Oncogene Proteins
Receptor, Fibroblast Growth Factor, Type 2
Serine
Signal Transduction
Tryptophan
bcl-2-Associated X Protein

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z01DK056001NIHNIH RePORTER
ZIADK056001NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.

PMIDTitleJournalYearIn PapersSource
42,633,326Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42633326PubMed
42,049,724The role of Pth1r in posterior cranium cartilage regulation and craniosynostosis.Nat Commun2026https://conductscience.org/library/papers/42049724PubMed
41,632,539Stem cell-associated osteogenic deficiency causes craniofacial deformities with progeroid accumulation of prelamin A.JCI Insight2026https://conductscience.org/library/papers/41632539PubMed
41,318,657RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion.Cell Death Dis2025https://conductscience.org/library/papers/41318657PubMed
41,151,533FGF receptor 2 signaling in granulosa cells is required for normal female fertility in mice.Reproduction2025https://conductscience.org/library/papers/41151533PubMed
40,261,605Insight into Apert Syndrome: Reporting on Six Patients and Increasing Awareness.Mol Neurobiol2025https://conductscience.org/library/papers/40261605PubMed
39,158,595New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities.J Mol Med (Berl)2024https://conductscience.org/library/papers/39158595PubMed
39,096,036Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis.J Anat2024https://conductscience.org/library/papers/39096036PubMed
38,814,743Mesenchymal Wnts are required for morphogenetic movements of calvarial osteoblasts during apical expansion.Development2024https://conductscience.org/library/papers/38814743PubMed
38,602,508Apical expansion of calvarial osteoblasts and suture patency is dependent on fibronectin cues.Development2024https://conductscience.org/library/papers/38602508PubMed

1 to 10 of 82

See all 82 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FGFR22,263PubTator's text mininghttps://conductscience.org/library/genes/2263

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14499350

GET https://conductscience.org/api/papers/v1/14499350/cited_by?page=2